The efficacy of amantadine in the symptomatic treatment of patients with Parkinson's
disease, discovered serendipitously more than 50 years ago, has stood the test of time and …

Objective: The objective of this review was to update evidence‐based medicine
recommendations for treating motor symptoms of Parkinson's disease (PD). Background …

Abstract Background and Purpose This update of the treatment guidelines was
commissioned by the European Academy of Neurology and the European section of the …

Importance Parkinson disease is the second most common neurodegenerative disease
worldwide. Although no available therapies alter the underlying neurodegenerative process …

Dementia with Lewy bodies and Parkinson's disease dementia, jointly known as Lewy body
dementia, are common neurodegenerative conditions. Patients with Lewy body dementia …

[Frontiers in Bioscience S6, 65-74, January 1, 2014] 65 Parkinson’s disease: a review Janice M.
Beitz1 1School of Nursing-Camd Page 1 [Frontiers in Bioscience S6, 65-74, January 1, 2014] …

Background: Lack of a global consensus on the definition of advanced Parkinson's disease
(APD) and considerations for timing of device-aided therapies may result in heterogeneity in …

Background The subthalamic nucleus is the preferred neurosurgical target for deep-brain
stimulation to treat cardinal motor features of Parkinson's disease. Focused ultrasound is an …

Since the official and systematic inclusion of sex and gender in biomedical research, gender
differences have been acknowledged as important determinants of both the susceptibility to …

6 Guidelines((“guideline”[pt] OR “practice guideline”[pt] OR “health planning guidelines”[mh]
OR “consensus development conference”[pt] OR “consensus development conference …